OncoPro Comprehensive Cancer Panel 161 Genes Test
Comprehensive Genetic Analysis for Personalized Cancer Care
The OncoPro Comprehensive Cancer Panel 161 Genes Test represents a revolutionary advancement in cancer diagnostics, offering unprecedented insights into the genetic drivers of cancer. This sophisticated molecular testing platform utilizes next-generation sequencing technology to analyze 161 cancer-related genes simultaneously, providing oncologists with comprehensive data to guide personalized treatment decisions and improve patient outcomes.
What This Advanced Cancer Panel Measures
This comprehensive genetic test provides detailed analysis across multiple genetic alteration types:
- 86 Hotspot Genes: Identifies specific mutations in key cancer driver genes known to influence treatment response
- 47 Full-Length Genes: Provides complete sequencing of critical cancer-associated genes for comprehensive mutation detection
- Copy Number Variations in 43 Genes: Detects gene amplifications and deletions that can significantly impact cancer progression
- Fusions in 48 Genes: Identifies gene fusion events that create novel oncogenic proteins and drive tumor growth
Who Should Consider This Comprehensive Cancer Genetic Testing
This advanced genetic panel is particularly valuable for patients experiencing:
- Newly diagnosed solid tumors requiring comprehensive genetic profiling
- Advanced or metastatic cancer where targeted therapy options are being considered
- Rare or difficult-to-treat cancers where standard treatment approaches have limited efficacy
- Family history of cancer suggesting potential hereditary cancer syndromes
- Previous treatment resistance requiring alternative therapeutic strategies
- Multiple primary cancers suggesting underlying genetic predisposition
Significant Benefits of Comprehensive Genetic Testing
Choosing the OncoPro Comprehensive Cancer Panel offers numerous advantages for cancer management:
- Personalized Treatment Planning: Identifies specific genetic alterations that can be targeted with precision therapies
- Clinical Trial Matching: Reveals genetic biomarkers that may qualify patients for cutting-edge clinical trials
- Prognostic Information: Provides insights into cancer aggressiveness and potential treatment response
- Hereditary Risk Assessment: Helps identify inherited cancer predisposition that may affect family members
- Treatment Resistance Monitoring: Detects emerging resistance mutations that may require therapy adjustments
- Comprehensive Biomarker Analysis: Single test provides multiple biomarker results, reducing the need for sequential testing
Understanding Your Genetic Test Results
Your comprehensive genetic report will provide detailed information about detected mutations and their clinical significance:
- Actionable Mutations: Genetic alterations with established targeted therapy options
- Investigational Targets: Mutations that may qualify for clinical trials or emerging therapies
- Prognostic Markers: Genetic changes that provide information about disease course and outcomes
- Resistance Mutations: Genetic alterations associated with treatment resistance
- Germline Findings: Potentially inherited mutations that may require additional genetic counseling
All results are interpreted by board-certified molecular pathologists and include clinical recommendations for your oncology team.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| OncoPro Comprehensive Cancer Panel 161 Genes Test | $1,228 USD | $1,366 USD |
Convenient Testing Process
Our testing process is designed for maximum convenience and reliability:
- Sample Collection: Submit formalin fixed paraffin embedded (FFPE) tissue block
- Sample Requirements: Block must contain at least 10% tumor tissue for accurate analysis
- Shipping: Ship at room temperature with appropriate packaging
- Turnaround Time: Samples processed daily by 11 AM; Reports delivered within 35 working days
Nationwide Accessibility
We have diagnostic branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many more. Our extensive network ensures that comprehensive cancer genetic testing is accessible to patients nationwide.
Take Control of Your Cancer Journey
Don’t leave your cancer treatment to chance. The OncoPro Comprehensive Cancer Panel 161 Genes Test provides the detailed genetic information needed to make informed treatment decisions and pursue the most effective therapeutic strategies. Our team of genetic specialists and oncology experts are ready to support you through every step of the testing process.
Ready to unlock the power of precision medicine? Book your comprehensive cancer genetic test today by calling our dedicated oncology genetic testing line at +1(267) 388-9828 or schedule your consultation through our online booking system.
